Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
27
APVO Quote, Financials, Valuation and Earnings
Last price:
$4.36
Seasonality move
:
-31.63%
Day range:
$4.23 - $4.73
52-week range:
$3.65 - $399.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
0.49x
Volume:
93K
Avg. volume:
354.7K
1-year change:
-98.55%
Market cap:
$2.2M
Revenue:
--
EPS (TTM):
-$3,598.31
Earnings Data
Next earnings date for APVO
Mar 05
2025
Most recent earnings per share
-$17.76
Beat by $3.33
(Nov 7/2024)
Consensus Estimate
-$21.09
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
APVO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2025 | Q4 | -- | -- | -- | -$7.75 | -- |
| 11/07/2024 | Q3 | -- | -- | -$17.76 | -$21.09 | $3.33 |
| 08/08/2024 | Q2 | -- | -- | -$2,718.76 | -$71.41 | -$2,647.35 |
| 05/08/2024 | Q1 | -- | -- | -$368.15 | -$475.27 | $107.12 |
| 03/05/2024 | Q4 | -- | -- | -$493.64 | -$667.48 | $173.84 |
| 11/14/2023 | Q3 | -- | -- | -$819.92 | -$1,221.00 | $401.08 |
| 06/30/2023 | Q2 | -- | -- | -$1,996.15 | -$1,823.36 | -$172.79 |
| 03/31/2023 | Q1 | -- | -- | $643.06 | -$1,774.52 | $2,417.58 |
| 12/31/2022 | Q4 | -- | -- | -$1,546.60 | -$2,539.68 | $993.08 |
| 11/11/2022 | Q3 | -- | -- | -$2,442.00 | -$2,474.56 | $32.56 |
| 08/12/2022 | Q2 | -- | -- | $9,084.24 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$2,523.40 | -- | -- |
| 03/31/2022 | Q4 | -- | -- | -$2,067.56 | -- | -- |
| 11/12/2021 | Q3 | -- | -- | -$2,328.04 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$2,849.00 | -- | -- |
| 05/11/2021 | Q1 | -- | -- | -$2,669.92 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$3,125.76 | -- | -- |
| 11/10/2020 | Q3 | -- | -- | -$3,418.80 | -- | -- |
| 08/07/2020 | Q2 | -- | -- | -$3,418.80 | -- | -- |
| 05/13/2020 | Q1 | -- | -- | $1,448.92 | -- | -- |
| 03/25/2020 | Q4 | -- | -- | -$3,874.64 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$3,500.20 | -- | -- |
| 08/09/2019 | Q2 | -- | -- | -$6,739.92 | -- | -- |
| 05/09/2019 | Q1 | -- | -- | -$12,437.92 | -- | -- |
| 03/18/2019 | Q4 | -- | -- | -$14,128.00 | -- | -- |
| 11/14/2018 | Q3 | -- | -- | -$12,637.83 | -- | -- |
| 08/09/2018 | Q2 | -- | -- | -$13,223.34 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$14,079.27 | -- | -- |
| 03/13/2018 | Q4 | -- | -- | -$10,306.23 | -- | -- |
| 11/13/2017 | Q3 | -- | -- | $40,284.04 | -- | -- |
| 08/10/2017 | Q2 | -- | -- | -$11,979.66 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$10,682.06 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$16,812.15 | -- | -- |
| 11/14/2016 | Q3 | -- | -- | -$80,789.41 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.64 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.64 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.89 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.63 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$0.55 | -- | -- |
Aptevo Therapeutics Earnings Questions
-
How Much did Aptevo Therapeutics Generate in Revenue Last Quarter?
Aptevo Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Aptevo Therapeutics Beat Earnings Last Quarter?
Aptevo Therapeutics announced earnings per share of -$17.76 which represents a beat of analyst forecast a -$21.09 per share.
-
Is Aptevo Therapeutics Profitable?
Aptevo Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Aptevo Therapeutics EPS Next Year?
Aptevo Therapeutics's earnings are forecast to decrease from -$2,311.76 per share to -$3,622.30 per share next year representing a decrease of -95.57%.
-
When is Aptevo Therapeutics's Earnings Date?
Aptevo Therapeutics's next earnings date is March 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
